基于NHANES数据的糖尿病患者的血糖控制和前列腺抗原水平
Xiao Huo1, Zhi Wang2, Nan Huang3
1Department of Oncology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Scientific reports
|May 6, 2025
概括
糖尿病中的血糖控制通常不会影响前列腺特异性抗原 (PSA) 水平. 然而,低血糖控制可能与年轻男性,胰岛素使用者和没有冠状动脉疾病的人的低PSA有关.
科学领域:
- 内分泌学 在内分泌学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 公共卫生 公共卫生
背景情况:
- 糖尿病是一种慢性疾病,影响全球数百万人.
- 前列腺特异性抗原 (PSA) 是前列腺癌查的关键生物标志物.
- 糖尿病,血糖控制和PSA水平之间的相互作用需要进一步研究.
研究的目的:
- 为了研究通过糖化血红蛋白 (HbA1c) 测量的血糖控制和糖尿病成年人的PSA总水平 (tPSA) 之间的关联.
- 探索HbA1c和tPSA之间的潜在子组特定关系.
主要方法:
- 分析了2001-2010年国家健康和营养检查调查 (NHANES) 的数据.
- 血糖控制的分类是好 (<7% HbA1c) 和差 (≥7% HbA1c).
- 多变量回归模型根据人口统计,临床和生活方式因素进行调整,使用邦费罗尼校正和多重归算缺失的数据.
主要成果:
- 在多变量分析中,在HbA1c和tPSA水平之间没有发现总体显著的关联 (β = -0.022,P = 0.917).
- 在良好的血糖控制组 (1.10 ng/mL) 与较差的控制组 (0.90 ng/mL) 相比,观察到更高的中位数tPSA.
- 在特定小组中发现了HbA1c和tPSA之间的显著反向关联:年轻人 (≤59岁),已婚参与者,没有冠状动脉疾病 (CAD) 的人和胰岛素使用者.
结论:
- 糖尿病的整体血糖控制似乎没有显著影响总PSA水平.
- 小组分析表明,HbA1c可能与tPSA在年轻患者,胰岛素使用者和没有CAD的个体中相反相关.
- 这些发现强调了血糖控制对糖尿病人群中前列腺健康标志物的潜在亚组特异性影响.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes: Symptoms, Diagnosis, and Complications
483
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
483
Psychoneuroimmunology: Diabetes and Cancer
19
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
19
Hypoglycemia and Glucagon
142
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
142
Hormones Regulating Blood Glucose
2.9K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
2.9K
Diabetes: Management and Pharmacotherapy
212
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
212


